ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

In Congress; Senate Ok’s $185 Mil. Addition For Breast Cancer

October 2, 1992

ACS Asks Reagan To Back Stronger Cigarette Warning

April 2, 1982

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

June 5, 2009

NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors

July 12, 1991

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973